Long-Term Persistence of Mitochondrial DNA Instability in HIV-Exposed Uninfected Children during and after Exposure to Antiretroviral Drugs and HIV.
HIV
clinical outcomes
genetic alterations
mitochondria
neonates
neurodevelopment
Journal
Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304
Informations de publication
Date de publication:
25 Jul 2022
25 Jul 2022
Historique:
received:
08
06
2022
revised:
18
07
2022
accepted:
20
07
2022
entrez:
27
7
2022
pubmed:
28
7
2022
medline:
28
7
2022
Statut:
epublish
Résumé
HIV-exposed uninfected (HEU) children show impaired health outcomes during childhood. A high rate of mitochondrial DNA (mtDNA) instability was reported in the blood of HEU at birth. We aimed to explore the relationship between these health outcomes and mtDNA deletions over time in a case series of 24 HEU children. MtDNA instability was assessed by deep sequencing and analyzed by eKLIPse-v2 algorithm at three time points, namely birth, 1 year, and 6 years of age. Association between mtDNA deletion and health outcomes, including growth, clinical, and neurodevelopmental parameters, were explored using univariate statistical analyses and after stratification with relevant variables. HEU children were selected with an equal male:female ratio. An elevated number of mtDNA deletions and duplications events was observed at 7 days' post-partum. Median heteroplasmy increased at one year of life and then returned to baseline by six years of age. The mtDNA instability was acquired and was not transmitted by the mother. No risk factors were significantly associated with mtDNA instability. In this small case series, we did not detect any association between any health outcome at 6 years and mtDNA instability measures. A significant effect modification of the association between the duration of maternal prophylaxis and child growth was observed after stratification with heteroplasmy rate. Genomic instability persists over time among HEU children but, despite its extension, stays subclinical at six years.
Identifiants
pubmed: 35892686
pii: biomedicines10081786
doi: 10.3390/biomedicines10081786
pmc: PMC9331317
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Agence Nationale de Recherches sur le Sida et les Hépatites Virales
ID : ANRS#12274 / ANRS#12341 / ANRS12174-B90
Organisme : European & Developing Countries Clinical Trials Partnership
ID : #CT.2006.33020.004
Organisme : The Research Council of Norway
ID : GlobVac grant # 183600
Déclaration de conflit d'intérêts
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Références
Aging Cell. 2019 Dec;18(6):e13018
pubmed: 31407474
PLoS Genet. 2020 Dec 14;16(12):e1009242
pubmed: 33315859
AIDS. 2004 Apr 30;18(7):1013-21
pubmed: 15096804
J Antimicrob Chemother. 2018 Nov 1;73(11):3114-3121
pubmed: 30351437
J Virol. 2018 Oct 29;92(22):
pubmed: 30158296
Clin Exp Immunol. 2014 Apr;176(1):11-22
pubmed: 24325737
Biochem Soc Trans. 2019 Dec 20;47(6):1757-1772
pubmed: 31696924
Genome Biol. 2020 Sep 17;21(1):248
pubmed: 32943091
J Clin Med. 2020 Sep 14;9(9):
pubmed: 32937988
Cell Metab. 2016 Jul 12;24(1):3-4
pubmed: 27411002
Genet Med. 2021 Sep;23(9):1769-1778
pubmed: 34040194
Nat Rev Dis Primers. 2016 Oct 20;2:16080
pubmed: 27775730
J Inherit Metab Dis. 2021 Jan;44(1):22-41
pubmed: 32618366
J Infect Dis. 2021 Feb 24;223(4):621-631
pubmed: 32638023
J Clin Med. 2021 May 28;10(11):
pubmed: 34071681
J Biol Chem. 2001 Oct 12;276(41):38097-107
pubmed: 11477094
J Med Toxicol. 2014 Mar;10(1):26-39
pubmed: 23963694
J Neurovirol. 2022 Apr;28(2):281-290
pubmed: 35157246
Mutat Res Genet Toxicol Environ Mutagen. 2021 May;865:503336
pubmed: 33865542
J Clin Med. 2020 Nov 16;9(11):
pubmed: 33207772
Nucleic Acids Res. 2020 Nov 18;48(20):11244-11258
pubmed: 33021629
Genet Med. 2019 Jun;21(6):1407-1416
pubmed: 30393377
Lancet. 2016 Feb 6;387(10018):566-573
pubmed: 26603917
Front Genet. 2018 Dec 11;9:632
pubmed: 30619459
Cell Metab. 2017 Jan 10;25(1):57-71
pubmed: 28094012
J Clin Invest. 2018 Aug 31;128(9):3662-3670
pubmed: 30059016
Lancet. 2021 Apr 3;397(10281):1316-1324
pubmed: 33812490
Mutat Res Genet Toxicol Environ Mutagen. 2016 Jul;805:1-6
pubmed: 27402477
Environ Mol Mutagen. 2016 Aug;57(7):526-34
pubmed: 27452341
Neurology. 2021 Jul 13;97(2):e156-e165
pubmed: 33947785
Toxicol Sci. 2010 Nov;118(1):191-201
pubmed: 20702595
Cells. 2021 Jan 16;10(1):
pubmed: 33467074
Open Biol. 2020 May;10(5):200061
pubmed: 32428418
Curr Biol. 2006 Jul 25;16(14):R551-60
pubmed: 16860735
Drug Chem Toxicol. 2020 Jul;43(4):429-434
pubmed: 30208744
J Biol Chem. 2001 Oct 19;276(42):38555-62
pubmed: 11504725
Sci Rep. 2021 Feb 4;11(1):3173
pubmed: 33542437
Front Genet. 2020 May 26;11:497
pubmed: 32528527
Front Aging. 2022;2:
pubmed: 35252966
Carcinogenesis. 2020 Dec 31;41(12):1625-1634
pubmed: 33146705
Biochem Biophys Res Commun. 2010 Mar 19;393(4):740-5
pubmed: 20171163
Clin Infect Dis. 2021 Jul 15;73(2):e466-e473
pubmed: 32722761
Curr HIV/AIDS Rep. 2019 Dec;16(6):501-513
pubmed: 31732866